Article Details

Goldman Sachs Group Reiterates “$20.00” Price Target for Cellectis (NASDAQ:CLLS)

Retrieved on: 2019-08-22 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs Group Reiterates “$20.00” Price Target for Cellectis (NASDAQ:CLLS). View article details on hiswai:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP acquired a new position in Cellectis in the fourth quarter valued at approximately $180,000. 31.95% of the stock is ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up